Researchers have unveiled the drug, a potential approach targeting a particular target involved in tumour development. Initial data suggest that Codrituzumab shows notable effectiveness in preclinical models , potentially representing a fresh prospect for patients battling this challenging condition. Additional investigation are determine its safet